Ricarda Weiland and Maaike van Boven received a prize for best poster at the Dutch Neuroscience Meeting 2019. In their winning poster they presented their first results in the BECAUSE project, in which they investigate mechanisms involved in sensory sensitivity in people with autism.

Together with clinicians and researchers from Utrecht, Nijmegen and Twente, CNCR researchers Verhage, Cornelisse, Meijer (FGA) and Linkenkaer-Hansen (INF) received a €1,8M grant to improve personalized medicine for children with autism.

The SYNGO Consortium, coordinated by CNCR scientists Frank Koopmans, Guus Smit and Matthijs Verhage, release the first deep annotation of synaptic genes and publish 1st paper in Neuron

Dr. Cillian King, Ana Rita Quadros and colleagues published their work on the modulation of cilia structure in the brain in Scientific Reports

Dr. Marieke Meijer and a team of FGA/CNCR researchers, together with iPSC-experts from the University of Bonn, published a novel method to study synapse formation and function in individual iPSC-derived human neurons in Cell Reports.

On Saturday the 13th of April, the STXBP1 research team welcomed a new group of STXBP1-E families at the VUmc for a second ‘Clinic day’.

Dr. Rik van der Kant (CNCR-FGA) and colleagues report that accumulation of cholesterol in Alzheimer’s disease neurons drives early Tau- and Amyloid pathology, and can be reversed by cholesterol-targeting drugs. Published in Cell Stem Cell.

On Saturday the 13th of October the first group of STXBP1-E families came to the VUmc to participate in the new study on STXBP1-Encephalopathy.

Claudia Persoon (CNCR-FGA) & the DCV team published a study on how many secretory vesicles are found in different CNS neurons (this paper is about vesicle pools, not swimming pools!) and how many vesicles fuse upon stimulation. The paper is featured on the cover of EMBO J. this month.

On Oct. 13, the 1st STXBP1 Patient Clinic Day will take place at VUmc in Amsterdam. The day is part of our studies on STXBP1-Encephalopathy (STXBP1-E) in a collaboration between FGA-CNCR, Clinical Genetics and VU spin-off company NBT Analytics.